The FDA has officially cleared the Dexcom G5 continuous glucose monitor to inform treatment decisions -- without the use of a fingerstick glucometer, other than for calibration. The G5 has been ...
The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...
For the first time, the US Food and Drug Administration has approved the use of a continuous glucose monitoring (CGM) system to replace finger-stick testing for determining insulin doses. The decision ...
Dexcom is also consistently rated the #1 CGM brand in independent patient surveys 5. In addition to integration with the t:slim X2 Pump, dynamic glucose data from the Dexcom G5 Mobile CGM can be ...
The move was cheered by a packed room of diabetes patients, parents, advocates, and doctors. Some see the change as a first step toward getting Medicare to cover CGM. After hearing from supporters ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.
Traders raked in $4 billion in profit from their short positions in Tesla shares on Thursday after a public feud between President Donald Trump and CEO Elon Musk drove the biggest single-day drop in ...
Dexcom is in the middle of a direct-to-consumer advertising campaign for its G5 Mobile CGM System. Is this DTC strategy paying off? In coordination with a new product launch, Dexcom, Inc., a major ...
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, today announced the availability of enhanced data sharing features for physician and patient users of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results